Over the past decade, countless therapies have been developed and approved by the Food and Drug Administration (FDA) for the treatment of melanoma. What’s interesting to note about melanoma, is...
The traditional treatment algorithm for advanced GISTs has been imatinib as first-line therapy, sunitinib as second-line therapy, and regorafenib as third-line therapy. Now, however, the GIST treatment landscape is evolving...
Hepatocellular Carcinoma has seen an incredible amount of advances in the last 5-years. The treatment landscape has shifted so much and with so many therapy options. Experts in HCC break...
